BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4147009)

  • 21. Requirement of thymus-derived theta-positive lymphocytes for rejection of DNA virus (SV 40) tumors in mice.
    Tevethia SS; Blasecki JW; Waneck G; Goldstein AL
    J Immunol; 1974 Nov; 113(5):1417-23. PubMed ID: 4371155
    [No Abstract]   [Full Text] [Related]  

  • 22. Cellular immunoadsorbents. An improved technique for specific depletion of cytotoxic (T) lymphoid cells.
    Kedar E; Ortiz de Landazuri M; Bonavida B; Fahey JL
    J Immunol Methods; 1974 May; 5(1):97-102. PubMed ID: 4546233
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibody dependent cellular cytotoxicity: cytotoxicity mediated by non t-lymphocytes.
    Zighelboim J; Gale RP; Chiu A; Bonavida B; Ossorio RC; Fahey JL
    Clin Immunol Immunopathol; 1974 Nov; 3(2):193-200. PubMed ID: 4548867
    [No Abstract]   [Full Text] [Related]  

  • 24. Suppressor T cells.
    Gershon RK; Cohen P; Hencin R; Liebhaber SA
    J Immunol; 1972 Mar; 108(3):586-90. PubMed ID: 4401006
    [No Abstract]   [Full Text] [Related]  

  • 25. Rosette formation by guinea pig thymocytes and thymus derived lymphocytes with rabbit red blood cells.
    Stadecker MJ; Bishop G; Wortis HH
    J Immunol; 1973 Dec; 111(6):1834-7. PubMed ID: 4201559
    [No Abstract]   [Full Text] [Related]  

  • 26. Relative resistance of early memory cells in mice primed with sheep erythrocytes to cytotoxic effects of anti-theta serum.
    Byfield P; Salerno A
    Cell Immunol; 1973 May; 7(2):328-31. PubMed ID: 4540900
    [No Abstract]   [Full Text] [Related]  

  • 27. Elimination of suppressor T-cells in mice undergoing a graft-versus-host reaction expressed by increased response to polyvinylpyrrolidone (PVP).
    Rotter V; Trainin N
    Cell Immunol; 1975 Jul; 18(1):199-209. PubMed ID: 237632
    [No Abstract]   [Full Text] [Related]  

  • 28. Significance of antigen binding by T cells.
    Charreire J; Bach JF
    Transplant Proc; 1973 Dec; 5(4):1735-7. PubMed ID: 4130079
    [No Abstract]   [Full Text] [Related]  

  • 29. Regulation and suppression of graft-versus-host reaction.
    Nouza K; Pichlílová
    Allerg Immunol (Leipz); 1973; 19(2-4):279-89. PubMed ID: 4156162
    [No Abstract]   [Full Text] [Related]  

  • 30. Rosette formation by a mouse fibroblast cell line.
    Elliott EV; Kerbel RS; Phillips BJ
    Nature; 1974 Apr; 248(448):514-5. PubMed ID: 4856807
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of spontaneous rosette formation with sheep red blood cells after adherence of fibroblasts to the substrate.
    Fornůsek L; Kousalová M; Viklický V
    Folia Biol (Praha); 1979; 25(6):401-2. PubMed ID: 230095
    [No Abstract]   [Full Text] [Related]  

  • 32. The functions of immune T and B rosette-forming cells.
    Hall W
    Immunology; 1973 Aug; 25(2):158-96. PubMed ID: 4582160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppressive and immunostimulatory factors produced by malignant cells in vitro.
    Wong A; Mankovitz R; Kennedy JC
    Int J Cancer; 1974 Apr; 13(4):530-42. PubMed ID: 4601698
    [No Abstract]   [Full Text] [Related]  

  • 34. Immune responses in vitro. VII. Loss of susceptibility of functional theta-bearing cells to cytotoxic action of anti-theta serum and complement in vitro.
    Pierce CW
    Cell Immunol; 1973 Dec; 9(3):465-73. PubMed ID: 4586158
    [No Abstract]   [Full Text] [Related]  

  • 35. A mechanism for the unresponsive state in BALB-c mice after repeated doses of sheep erythrocytes.
    Thomson PD; Jutila JW
    J Immunol; 1972 Oct; 109(4):742-8. PubMed ID: 4627508
    [No Abstract]   [Full Text] [Related]  

  • 36. Cytotoxicity of human rosette-forming blood lymphocytes on cultivated human tumor cells.
    Wybran J; Hellström I; Hellström KE; Fudenberg HH
    Int J Cancer; 1974 Apr; 13(4):515-21. PubMed ID: 4546321
    [No Abstract]   [Full Text] [Related]  

  • 37. Reactivation of radioresistant F1-specific parental cells by F1 T cells. Preliminary evidence for a semiallogeneic T-T cell interaction.
    Gleichmann E; Gleichmann H; Schiedewitz H; Scheele R
    Transplantation; 1976 Jan; 21(1):77-81. PubMed ID: 54968
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of macrophages, thymus- and bone marrow-derived cells in the graft-versus-host reaction.
    Argyris B
    Transplantation; 1974 Apr; 17(4):387-91. PubMed ID: 4150882
    [No Abstract]   [Full Text] [Related]  

  • 39. Relationship between proliferative and effector phases of the mixed lymphocyte reaction and graft-vs-host reaction.
    Howe M; Berman L; Cohen L
    J Immunol; 1973 Oct; 111(4):1243-9. PubMed ID: 4147022
    [No Abstract]   [Full Text] [Related]  

  • 40. Stimulation of in vitro antibody responses to sheep red cells by thymus cells activated to histocompatibility antigens.
    Vann DC; Galloway PC
    J Immunol; 1973 Jun; 110(6):1542-53. PubMed ID: 4541306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.